Details

Karakterizacija izločevalno utrjevalnega jekla UTOPNiCu : diplomsko delo
ID Lečnik, Miha (Author), ID Markoli, Boštjan (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (6,28 MB)
MD5: 0CE6EFE27EF36D940B9728D98453D754
PID: 20.500.12556/rul/3b66d646-79bb-41b3-ab4b-a59b15db9b04

Language:Slovenian
Keywords:UTOPNiCu, izločevalno utrjevanje, mehanske lastnosti, izločki
Work type:Bachelor thesis/paper
Typology:2.11 - Undergraduate Thesis
Organization:NTF - Faculty of Natural Sciences and Engineering
Place of publishing:Ljubljana
Publisher:[M. Lečnik]
Year:2015
Number of pages:VI, 34 f.
PID:20.500.12556/RUL-73340 This link opens in a new window
UDC:669.1
COBISS.SI-ID:1560159 This link opens in a new window
Publication date in RUL:04.11.2015
Views:24419
Downloads:645
Metadata:XML DC-XML DC-RDF
:
LEČNIK, Miha, 2015, Karakterizacija izločevalno utrjevalnega jekla UTOPNiCu : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : M. Lečnik. [Accessed 24 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=73340
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Keywords:steel UTOPNiCu, precipitation hardening, mechanical properties, precipitates

Similar documents

Similar works from RUL:
  1. Pomen tumorskih matičnih celic in epitelno-mezenhimskega prehoda pri napredovanju nedrobnoceličnega raka pljuč
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Proučevanje izražanja gena za fosfatidiletanolamin-N-metiltransferazo v nedrobnoceličnem pljučnem rakavem tkivu
  4. Uporabnost imunohistokemičnega določanja mutacij receptorja za epidermalni rastni faktor pri raku pljuč
  5. Sladkorna bolezen in športna vadba
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back